We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
+5.05%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$787M
AUM Growth
-$24.3M
Cap. Flow
-$58.4M
Cap. Flow %
-7.41%
Top 10 Hldgs %
35.43%
Holding
86
New
1
Increased
12
Reduced
49
Closed
5

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$13.5M
2
R icon
Ryder
R
+$5.64M
3
IBN icon
ICICI Bank
IBN
+$4.68M
4
JBL icon
Jabil
JBL
+$4.55M
5
BHI
Baker Hughes
BHI
+$4.14M

Sector Composition

Rank Sector Weight
1 Healthcare 23.58%
2 Technology 15.83%
3 Financials 15.07%
4 Energy 11.76%
5 Consumer Staples 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NSC icon
26
Norfolk Southern
NSC
$76.4B
$12.7M 1.61%
123,225
-7,490
-6% -$735K
PPL
27
PPL Corp
PPL
$27B
$11.7M 1.48%
353,256
-25,662
-7% -$809K
COP icon
28
ConocoPhillips
COP
$140B
$11.4M 1.45%
133,458
-14,210
-10% -$1.11M
CSX icon
29
CSX Corp
CSX
$94.3B
$10.5M 1.34%
1,026,642
-4,287
-0.4% -$41.7K
ANF icon
30
Abercrombie & Fitch
ANF
$4.23B
$10.4M 1.32%
239,519
-26,929
-10% -$1.04M
MRK icon
31
Merck
MRK
$315B
$10.1M 1.29%
183,758
-50,409
-22% -$2.75M
TDC icon
32
Teradata
TDC
$2.87B
$9.87M 1.25%
245,545
-750
-0.3% -$32.7K
DOX icon
33
Amdocs
DOX
$5.59B
$9.65M 1.23%
208,390
-6,590
-3% -$310K
SWK icon
34
Stanley Black & Decker
SWK
$14B
$9.64M 1.22%
109,720
-6,430
-6% -$548K
VIV icon
35
Telefônica Brasil
VIV
$22.3B
$9.58M 1.22%
467,217
-36,479
-7% -$753K
TAP icon
36
Molson Coors Class B
TAP
$7.68B
$9.38M 1.19%
126,501
-1,560
-1% -$101K
F icon
37
Ford
F
$56.7B
$9.26M 1.18%
537,199
-24,200
-4% -$394K
MAT icon
38
Mattel
MAT
$4.16B
$9.24M 1.17%
237,062
-6,210
-3% -$241K
HWC icon
39
Hancock Whitney
HWC
$6.37B
$8.36M 1.06%
236,653
-8,580
-3% -$296K
KN icon
40
Knowles
KN
$3.01B
$8.34M 1.06%
271,289
+154,630
+133% +$4.68M
DVN icon
41
Devon Energy
DVN
$50.6B
$8.13M 1.03%
102,327
-29,043
-22% -$2.11M
CAH icon
42
Cardinal Health
CAH
$53.5B
$7.5M 0.95%
109,372
-17,020
-13% -$1.16M
TPR icon
43
Tapestry
TPR
$28.6B
$7.36M 0.93%
215,274
+3,593
+2% +$154K
DD
44
DELISTED
Du Pont De Nemours E I
DD
$7.28M 0.92%
117,122
-27,157
-19% -$1.75M
PTR
45
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$6.73M 0.85%
53,570
-3,224
-6% -$380K
SNY icon
46
Sanofi
SNY
$107B
$5.33M 0.68%
100,179
+1,216
+1% +$64.5K
SBS icon
47
Sabesp
SBS
$20.2B
$4.84M 0.61%
2,327,943
-44,986
-2% -$86.2K
RDS.A
48
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$4.71M 0.6%
57,145
-932
-2% -$72.9K
PUK icon
49
Prudential
PUK
$35.2B
$4.67M 0.59%
104,870
+642
+0.6% +$28.5K
KT icon
50
KT
KT
$8.36B
$4.62M 0.59%
305,189
+27,697
+10% +$421K

Similar funds

Foyston, Gordon, & Payne's Q2 2014 Portfolio in Review

As of Q2 2014, Foyston, Gordon, & Payne held 86 positions worth $787M, down 3% from $812M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Foyston, Gordon, & Payne withdrew a net $58.4M in Q2 2014, closing 5 positions and reducing 49 holdings. Its most notable exit was iShares Russell 2000 ETF, an estimated $13.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 20% a quarter earlier, followed by Technology and Financials.

Against the trend, Foyston, Gordon, & Payne opened a new position in Compañía de Cervecerías Unidas worth $693K.

  • Foyston, Gordon, & Payne's largest Q2 2014 buy was Compañía de Cervecerías Unidas: 29,600 shares worth $693K.
  • Foyston, Gordon, & Payne added most to Teva Pharmaceuticals in Q2 2014, an estimated $16M increase.
  • Foyston, Gordon, & Payne's biggest Q2 2014 reduction was Ryder, cutting an estimated $5.64M.
  • Foyston, Gordon, & Payne fully exited iShares Russell 2000 ETF in Q2 2014, selling an estimated $13.5M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 35% of its $787M portfolio in Q2 2014.
  • Foyston, Gordon, & Payne opened 1 new position and closed 5 in Q2 2014.
  • Foyston, Gordon, & Payne's portfolio value fell 3% quarter-over-quarter to $787M.

Based on Foyston, Gordon, & Payne's 13F filing for Q2 2014, filed 14 Aug 2014.